PMID: 42295649

Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response.

Mian Muhammad Hamid Siddique, Janahi Kholood Abdulla Hasan Abdulla, Tayeb Afnan, Musaffar Fathima Musfira Mohamad, Al Sheykh Khalil Nur, Al Toubah Sarah Hisham, Karim Abdul Moen Abdul, Almarzooqi Ahlam, Sayfoo Fardeen Mohammad, Hamadeh Ahmed

Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026

This entry links to third-party literature. For research use only.